CYP1A1 and CYP1B1 genetic variations might change enzymes functional characteristics in PAHs metabolism and ultimately influence the risk of CRC, which is increasing in Kirkuk governorate (Al Dahhan and Al Lami, 2018). The gene discussed is CYP1A1; the disease is colorectal carcinoma.